Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yi Gu*Jie Zeng*Yixin Zou, Chang Liu, Hongjuan Fu & Hui Chang. (2022) Folate Intake and Risk of Urothelial Carcinoma: A Systematic Review and Meta-Analysis of Epidemiological Studies. Nutrition and Cancer 74:5, pages 1593-1605.
Read now
Read now
Ana Blanca, Maria J Requena, Jose Alvarez, Liang Cheng, Rodolfo Montironi, Maria R Raspollini, Carlos Reymundo & Antonio Lopez-Beltran. (2016) FGFR3 and Cyclin D3 as Urine Biomarkers of Bladder Cancer Recurrence. Biomarkers in Medicine 10:3, pages 243-253.
Read now
Read now
Ranveig Røtterud, Per-Uno Malmström, Rolf Wahlqvist & Kristin A. Taskén. (2010) The star chart to Ta bladder cancer: An unsophisticated analysis of two-dimensional gel electrophoresis proteome maps. Scandinavian Journal of Urology and Nephrology 44:2, pages 76-83.
Read now
Read now
Margaret A. Knowles. (2008) Bladder cancer subtypes defined by genomic alterations. Scandinavian Journal of Urology and Nephrology 42:sup218, pages 116-130.
Read now
Read now
Articles from other publishers (65)
Jiu-ping Liang, Liang Yin, Li-kun Gao, Lei Yin, Wang Ren, Zhi-fa Jin, Li-peng Chen & Yi-yong Liu. (2024) Contrast-enhanced CT in the differential diagnosis of bladder cancer and paraganglioma. Abdominal Radiology 49:5, pages 1584-1592.
Crossref
Crossref
Fuchao Liang, Fei Zhou, Xiaoyuan Qian, Linghui Qin, Jiange Wang, Chen Ding, Yasen Kuniduzi, Xuejun Zhang & Lianming Fan. (2023) Association between radiotherapy and prognosis in patients with small cell carcinoma of the bladder undergoing bladder-sparing surgery. Frontiers in Oncology 13.
Crossref
Crossref
Seyed Amir Miratashi Yazdi, Farnoosh Asghari, Hedieh Moradi Tabriz, Behnoud Vesali & Elham Nazar. (2023) The Value of Epidermal Growth Factor Receptor Expression in Predicting Aggressive Behaviors of Bladder Neoplasms. Nephro-Urology Monthly 15:2.
Crossref
Crossref
Christopher A. Lucchesi, Demitria M. Vasilatis, Saisamkalpa Mantrala, Thenappan Chandrasekar, Maria Mudryj & Paramita M. Ghosh. (2023) Pesticides and Bladder Cancer: Mechanisms Leading to Anti-Cancer Drug Chemoresistance and New Chemosensitization Strategies. International Journal of Molecular Sciences 24:14, pages 11395.
Crossref
Crossref
Gaoxiu Qi, Jinmeng Liu, Shuqi Tao, Wenyuan Fan, Haoning Zheng, Meihong Wang, Hanchao Yang, Yongting Liu, Huancai Liu & Fenghua Zhou. (2023) A retrospective study on expression and clinical significance of PHH3, Ki67 and P53 in bladder exophytic papillary urothelial neoplasms. PeerJ 11, pages e15675.
Crossref
Crossref
Ana Blanca, Antonio Lopez-Beltran, Kevin Lopez-Porcheron, Enrique Gomez-Gomez, Alessia Cimadamore, Andreia Bilé-Silva, Rajan Gogna, Rodolfo Montironi & Liang Cheng. (2023) Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype. Cancers 15:7, pages 2149.
Crossref
Crossref
Shaoxu Wu, Guibin Hong, Abai Xu, Hong Zeng, Xulin Chen, Yun Wang, Yun Luo, Peng Wu, Cundong Liu, Ning Jiang, Qiang Dang, Cheng Yang, Bohao Liu, Runnan Shen, Zeshi Chen, Chengxiao Liao, Zhen Lin, Jin Wang & Tianxin Lin. (2023) Artificial intelligence-based model for lymph node metastases detection on whole slide images in bladder cancer: a retrospective, multicentre, diagnostic study. The Lancet Oncology 24:4, pages 360-370.
Crossref
Crossref
Alessandro Zucchi, Francesco Claps, Antonio Luigi Pastore, Alessandro Perotti, Andrea Biagini, Luana Sallicandro, Rosaria Gentile, Concetta Caglioti, Federico Palazzetti & Bernard Fioretti. (2023) Focus on the Use of Resveratrol in Bladder Cancer. International Journal of Molecular Sciences 24:5, pages 4562.
Crossref
Crossref
Abdalla El Azab, Ahmed Abdelbary, Aly El Faqeh M. Okasha, Hatem Aboulkassem, Ashraf Saad Zaghloul, Riham Mohamed Karkeet & Ibrahim Abdelrahman. (2023) The effect of immediate neoadjuvant electromotive instillation of mitomycin C with Bacillus Calmette–Guérin versus BCG alone in non-muscle-invasive bladder cancer: A randomized controlled trial. Investigative and Clinical Urology 64:6, pages 554.
Crossref
Crossref
Neha Bhattacharyya, Dipanjan Mukherjee, Soumendra Singh, Ria Ghosh, Saurav Karmakar, Ankita Mallick, Arpita Chattopadhyay, Pulak Mondal, Tapan Mondal, Debasis Bhattacharyya, Asim Kumar Mallick, Ghulam Nabi & Samir Kumar Pal. (2022) “Seeing” invisible volatile organic compound (VOC) marker of urinary bladder cancer: A development from bench to bedside prototype spectroscopic device. Biosensors and Bioelectronics 218, pages 114764.
Crossref
Crossref
Amirali Karimi, Parnian Shobeiri, Sina Azadnajafabad, Masoud Masinaei, Negar Rezaei, Ali Ghanbari, Nazila Rezaei, Mahtab Rouhifard, Sarvenaz Shahin, Mohammad-Mahdi Rashidi, Mohammad Keykhaei, Ameneh Kazemi, Erfan Amini, Bagher Larijani & Farshad Farzadfar. (2022) A global, regional, and national survey on burden and Quality of Care Index (QCI) of bladder cancer: The global burden of disease study 1990–2019. PLOS ONE 17:10, pages e0275574.
Crossref
Crossref
Derek B. Allison, Carla L. Ellis & Christopher J. VandenBussche. 2022. Genitourinary System Cytology and Small Biopsy Specimens. Genitourinary System Cytology and Small Biopsy Specimens
23
38
.
Antonio Lopez-Beltran, Alessia Cimadamore, Rodolfo Montironi & Liang Cheng. (2021) Molecular pathology of urothelial carcinoma. Human Pathology 113, pages 67-83.
Crossref
Crossref
Md. Shafiqur RahmanSanjeeb Bhakta BistaMd. Sayedul IslamA. S. M. Shafiul AzamMd. Shamim HossainFaika Farah Ahmed. (2021) RECURRENCE RATE AFTER REPEAT TRANSURETHRAL RESECTION AMONG PATIENTS WITH NEWLY DIAGNOSED T1 BLADDER CANCER. INDIAN JOURNAL OF APPLIED RESEARCH, pages 51-54.
Crossref
Crossref
Antonio Lopez-Beltran & Liang Cheng. (2021) Stage T1 bladder cancer: diagnostic criteria and pitfalls. Pathology 53:1, pages 67-85.
Crossref
Crossref
Hongxing Liu, Chaoming Mei, Xuanru Deng, Weiqiang Lin, Lizhen He & Tianfeng Chen. (2021) Rapid visualizing and pathological grading of bladder tumor tissues by simple nanodiagnostics. Biomaterials 264, pages 120434.
Crossref
Crossref
Vasudevan Thirugnanasambandam & Jeyaraman Ramanathan. (2020) Comparative study of histological changes (thermal artefacts) in resected specimens of monopolar and bipolar trans-urethral resection of bladder tumours. annals of urologic oncology, pages 1-7.
Crossref
Crossref
Eun‐Jung Cho, Chang Kwon Bang, Hyunjung Kim & Hae Kyung Lee. (2020) An ensemble approach of urine sediment image analysis and NMP22 test for detection of bladder cancer cells. Journal of Clinical Laboratory Analysis 34:8.
Crossref
Crossref
Sergey Kurilchik, Mauro Gacci, Riccardo Cicchi, Francesco S Pavone, Simone Morselli, Sergio Serni, MH Chou, Mikko Närhi, Edik Rafailov, Neil Stewart, Cordelia Lennon & Regina Gumenyuk. (2020) Advanced multimodal laser imaging tool for urothelial carcinoma diagnosis (AMPLITUDE). Journal of Physics: Photonics 2:2, pages 021001.
Crossref
Crossref
Diego M. Carrion, Juan Gómez Rivas, Cristina Ballesteros Ruiz, Mario Alvarez-Maestro, Alfredo Aguilera Bazán & Luis Martínez-Piñeiro. (2020) Precave: Immediate neoadjuvant instillation of chemotherapy for the prevention of non-muscle invasive bladder carcinoma recurrence: A prospective randomized clinical trial protocol. International Journal of Surgery Protocols 24, pages 21-26.
Crossref
Crossref
Angela B. Smith, Arjun V. Balar, Matthew I. Milowsky & Ronald C. Chen. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
1382
1400.e4
.
Jorge Rebola, Pedro Aguiar, Ana Blanca, Rodolfo Montironi, Alessia Cimadamore, Liang Cheng, Vanessa Henriques, Paula Lobato-Faria & Antonio Lopez-Beltran. (2019) Predicting outcomes in non-muscle invasive (Ta/T1) bladder cancer: the role of molecular grade based on luminal/basal phenotype. Virchows Archiv 475:4, pages 445-455.
Crossref
Crossref
Damian Jaworski, Łukasz Szylberg, Arkadiusz Gzil, Peter Stawinski, Anna Kasperska & Andrzej Marszałek. (2019) Diagnostic difficulties in cases of papillary urothelial neoplasm of low malignant potential, urothelial proliferation of uncertain malignant potential, urothelial dysplasia and urothelial papilloma: A review of current literature. Annals of Diagnostic Pathology 40, pages 182-188.
Crossref
Crossref
Sadaf Azad Raja, Seher Abbas, Syed Tahir Abbas Shah, Aamira Tariq, Nazia Bibi, Arzu Yousuf, Athar Khawaja, Muhammad Nawaz, Arshad Mehmood, Muhammad Jadoon Khan & Alamdar Hussain. (2019) Increased expression levels of Syntaxin 1A and Synaptobrevin 2/Vesicle-Associated Membrane Protein-2 are associated with the progression of bladder cancer. Genetics and Molecular Biology 42:1, pages 40-47.
Crossref
Crossref
Yongjia Liu, Ruibin Wang, Jingwen Hou, Binbin Sun, Bangshang Zhu, Zhiguang Qiao, Yue Su & Xinyuan Zhu. (2018) Paclitaxel/Chitosan Nanosupensions Provide Enhanced Intravesical Bladder Cancer Therapy with Sustained and Prolonged Delivery of Paclitaxel. ACS Applied Bio Materials 1:6, pages 1992-2001.
Crossref
Crossref
Peter A. Reisz, Aaron A. Laviana & Sam S. Chang. (2018) Management of High-grade T1 Urothelial Carcinoma. Current Urology Reports 19:12.
Crossref
Crossref
Xu Hu, Dahong Li, Chun Chu, Xu Li, Xianhua Wang, Ying Jia, Huiming Hua & Fanxing Xu. (2018) Antiproliferative Effects of Alkaloid Evodiamine and Its Derivatives. International Journal of Molecular Sciences 19:11, pages 3403.
Crossref
Crossref
Pierre‐Antoine Dugué, Maree T. Brinkman, Allison M. Hodge, Julie K. Bassett, Damien Bolton, Anthony Longano, John L. Hopper, Melissa C. Southey, Dallas R. English, Roger L. Milne & Graham G. Giles. (2018) Dietary intake of nutrients involved in one‐carbon metabolism and risk of urothelial cell carcinoma: A prospective cohort study. International Journal of Cancer 143:2, pages 298-306.
Crossref
Crossref
Naotaka Nishiyama, Hiroshi Hotta, Atsushi Takahashi, Masahiro Yanase, Naoki Itoh, Hitoshi Tachiki, Noriomi Miyao, Masanori Matsukawa, Yasuharu Kunishima, Keisuke Taguchi, Hiroshi Kitamura & Naoya Masumori. (2018) Upper tract urothelial carcinoma following intravesical bacillus Calmette-Guérin therapy for nonmuscle-invasive bladder cancer: Results from a multi-institutional retrospective study. Urologic Oncology: Seminars and Original Investigations 36:6, pages 306.e9-306.e15.
Crossref
Crossref
Yu. I. Osmanov, Zh. A. Gaibov, E. A. Kogan, S. G. Radenska-lopovok & Kh. Z. Tursunov. (2018) Comparative morphological characteristics and immunophenotype of urothelial carcinomas of the renal pelvis and bladder. Arkhiv patologii 80:5, pages 23.
Crossref
Crossref
Daisaku Hirano, Toshiyuki Yoshida, Daigo Funakoshi, Fuminori Sakurai, Shou Ohno & Yoshiaki Kusumi. (2018) A Case of Early Stage Bladder Carcinosarcoma in Late Recurrence of Urothelial Carcinoma after Transurethral Resection. Case Reports in Urology 2018, pages 1-4.
Crossref
Crossref
Zeliha Esin Celik, Mehmet Kaynar, Pinar Karabagli, Nursadan Gergerlioglu & Serdar Goktas. (2017) The relation between Ring Box-1 protein overexpression and tumor grade and stage in bladder urothelial cell carcinoma. Cancer Biomarkers 20:4, pages 389-394.
Crossref
Crossref
Cheng Chen, Linkun Hu, Ye Chen & Jianquan Hou. (2017) The prognostic value of histological subtype in patients with metastatic bladder cancer. Oncotarget 8:17, pages 28408-28417.
Crossref
Crossref
Umesh Jayarajah, D. M. Hilary Fernando, Kasun Bandara Herath, M. V. Chandu de Silva & S. A. S. Goonewardena. (2017) Primary Signet-Ring Cell Adenocarcinoma of the Urinary Bladder Treated with Partial Cystectomy: A Case Report and Review of the Literature. Case Reports in Urology 2017, pages 1-4.
Crossref
Crossref
Feng Chen, Tao Huang, Yu Ren, Junjun Wei, Zhongguan Lou, Xue Wang, Xiaoxiao Fan, Yirun Chen, Guobin Weng & Xuping Yao. (2016) Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis. BMC Urology 16:1.
Crossref
Crossref
Zhi-yu Wang, Wei Zhang, Jin-jian Yang, Dong-kui Song & Jin-xing Wei. (2016) Expression of miRNA-630 in bladder urothelial carcinoma and its clinical significance. Journal of Huazhong University of Science and Technology [Medical Sciences] 36:5, pages 705-709.
Crossref
Crossref
K. Sfetsas & D. Mitropoulos. (2016) Reducing understaging of bladder cancer with the aid of photodynamic cystoscopy. Journal of the Egyptian National Cancer Institute 28:2, pages 89-94.
Crossref
Crossref
I‐Hung Shao, Ying‐Hsu Chang, Kai‐Jie Yu, Po‐Hung Lin, Chung‐Yi Liu, Cheng‐Keng Chuang & See‐Tong Pang. (2016) Outcomes and prognostic factors of simple partial cystectomy for localized bladder urothelial cell carcinoma. The Kaohsiung Journal of Medical Sciences 32:4, pages 191-195.
Crossref
Crossref
Liang Cheng & Antonio Lopez-Beltran. 2016. Essentials of Anatomic Pathology. Essentials of Anatomic Pathology
1681
1735
.
Susanne Grimm, Susanne Jennek, Rajan Singh, Astrid Enkelmann, Kerstin Junker, Nora Rippaus, Alexander Berndt & Karlheinz Friedrich. (2015) Malignancy of bladder cancer cells is enhanced by tumor-associated fibroblasts through a multifaceted cytokine-chemokine loop. Experimental Cell Research 335:1, pages 1-11.
Crossref
Crossref
Antonio Lopez-Beltran, Carmen L. Menendez, Rodolfo Montironi & Liang ChengAntonio Lopez-Beltran, Carmen L. Menendez, Rodolfo Montironi & Liang Cheng. 2015. Rare Tumors and Tumor-like Conditions in Urological Pathology. Rare Tumors and Tumor-like Conditions in Urological Pathology
63
194
.
Jamie C. Messer, Sanoj Punnen, John Fitzgerald, Robert Svatek & Dipen J. Parekh. (2014) Health‐related quality of life from a prospective randomised clinical trial of robot‐assisted laparoscopic vs open radical cystectomy. BJU International 114:6, pages 896-902.
Crossref
Crossref
Bernd Wullich, Peter J. Goebell, Helge Taubert & Sven Wach. 2014. Nucleic Acids as Molecular Diagnostics. Nucleic Acids as Molecular Diagnostics
63
128
.
N. Nishiyama, H. Kitamura, H. Hotta, A. Takahashi, M. Yanase, N. Itoh, H. Tachiki, N. Miyao, M. Matsukawa, Y. Kunishima, K. Taguchi & N. Masumori. (2014) Construction of Predictive Models for Cancer-specific Survival of Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guerin: Results from a Multicenter Retrospective Study. Japanese Journal of Clinical Oncology 44:11, pages 1101-1108.
Crossref
Crossref
Hiro IshiiBhavan Prasad RaiJens-Uwe StolzenburgPradeep BosePiotr L. ChlostaBhaskar K. SomaniGhulam NabiHasan Abdur Rahman QaziKrishnamoorthy RajbabuHoward KynastonOmar M. Aboumarzouk. (2014) Robotic or Open Radical Cystectomy, Which Is Safer? A Systematic Review and Meta-Analysis of Comparative Studies. Journal of Endourology 28:10, pages 1215-1223.
Crossref
Crossref
M. Sathya & P. Chinnaswam. (2014) Urinary Bladder Cancer: A Clinicopathological and Histological Study. Journal of Medical Sciences 14:4, pages 206-209.
Crossref
Crossref
Angela Smith, Arjun V. Balar, Matthew I. Milowsky & Ronald C. Chen. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
1445
1462.e4
.
Manuel S. Eisenberg, Stephen A. Boorjian, John C. Cheville, R. Houston Thompson, Prabin Thapa, Dharam Kaushik & Igor Frank. (2013) The SPARC Score: A Multifactorial Outcome Prediction Model for Patients Undergoing Radical Cystectomy for Bladder Cancer. Journal of Urology 190:6, pages 2005-2010.
Crossref
Crossref
N. Nishiyama, H. Kitamura, T. Maeda, S. Takahashi, N. Masumori, T. Hasegawa & T. Tsukamoto. (2013) Clinicopathological Analysis of Patients with Non-muscle-invasive Bladder Cancer: Prognostic Value and Clinical Reliability of the 2004 WHO Classification System. Japanese Journal of Clinical Oncology 43:11, pages 1124-1131.
Crossref
Crossref
Michael C. Large, Joshua A. Cohn & Gary D. Steinberg. (2013) Optimal Risk-Adapted Surveillance Strategies for NMIBC, Including Upper Tract Imaging. Urologic Clinics of North America 40:2, pages 305-315.
Crossref
Crossref
Dipen J. Parekh, Jamie Messer, John Fitzgerald, Barbara Ercole & Robert Svatek. (2013) Perioperative Outcomes and Oncologic Efficacy from a Pilot Prospective Randomized Clinical Trial of Open Versus Robotic Assisted Radical Cystectomy. Journal of Urology 189:2, pages 474-479.
Crossref
Crossref
Wolfgang Otto, Matthias May, Hans-Martin Fritsche, Duska Dragun, Atiqullah Aziz, Michael Gierth, Lutz Trojan, Edwin Herrmann, Rudolf Moritz, Jörg Ellinger, Derya Tilki, Alexander Buchner, Thomas Höfner, Sabine Brookman-May, Philipp Nuhn, Christian Gilfrich, Jan Roigas, Mario Zacharias, Stefan Denzinger, Markus Hohenfellner, Axel Haferkamp, Stefan C. Müller, Arkadius Kocot, Hubertus Riedmiller, Wolf F. Wieland, Christian G. Stief, Patrick J. Bastian & Maximilian Burger. (2012) Analysis of Sex Differences in Cancer-Specific Survival and Perioperative Mortality Following Radical Cystectomy: Results of a Large German Multicenter Study of Nearly 2500 Patients with Urothelial Carcinoma of the Bladder. Gender Medicine 9:6, pages 481-489.
Crossref
Crossref
Liang Cheng, Antonio Lopez‐Beltran & David G. Bostwick. 2012. Bladder Pathology. Bladder Pathology
137
159
.
Liang Cheng, Antonio Lopez‐Beltran & David G. Bostwick. 2012. Bladder Pathology. Bladder Pathology
581
608
.
Manu Jain, Brian D. Robinson, Douglas S. Scherr, Joshua Sterling, Ming-Ming Lee, James Wysock, Mark A. Rubin, Frederick R. Maxfield, Warren R. Zipfel, Watt W. Webb & Sushmita Mukherjee. (2012) Multiphoton Microscopy in the Evaluation of Human Bladder Biopsies. Archives of Pathology & Laboratory Medicine 136:5, pages 517-526.
Crossref
Crossref
Ying-Li Lin, Xiao-Qiang Liu, Wen-Ping Li, Guang Sun & Chun-Ting Zhang. (2011) Promoter methylation of H-cadherin is a potential biomarker in patients with bladder transitional cell carcinoma. International Urology and Nephrology 44:1, pages 111-117.
Crossref
Crossref
Masayo Shuto, Atsushi Seyama, Yoshiya Gotoh, Kouichi Kamada, Masaru Nakamura, Kenji Warigaya, Hiroshi Watanabe, Munehisa Ueno, Michio Shimizu, Toshio Fukuda & Shin-ichi Murata. (2012) Significant Correlation between Chromosomal Aberration and Nuclear Morphology in Urothelial Carcinoma. ACTA HISTOCHEMICA ET CYTOCHEMICA 45:1, pages 25-33.
Crossref
Crossref
David P. WoodJr.Jr.. 2012. Campbell-Walsh Urology. Campbell-Walsh Urology
2309
2334.e6
.
Martine M. Ros, H.B. Bas Bueno‐de‐Mesquita, Frederike L. Büchner, Katja K.H. Aben, Ellen Kampman, Lars Egevad, Kim Overvad, Anne Tjønneland, Nina Roswall, Francoise Clavel‐Chapelon, Rudolf Kaaks, Jenny Chang‐Claude, Heiner Boeing, Steffen Weikert, Antonia Trichopoulou, Philippos Orfanos, Georgia Stasinopulou, Calogero Saieva, Vittorio Krogh, Paolo Vineis, Rosario Tumino, Amalia Mattiello, Petra H.M. Peeters, Fränzel J.B. van Duijnhoven, Eiliv Lund, Inger T Gram, Maria D Chirlaque, Aurelio Barricarte, Laudina Rodríguez, Esther Molina, Carlos Gonzalez, Miren Dorronsoro, Jonas Manjer, Roy Ehrnström, Börje Ljungberg, Naomi E. Allen, Andrew W. Roddam, Kay‐Tee Khaw, Nick Wareham, Paolo Boffetta, Nadia Slimani, Dominique S. Michaud, Lambertus A.L.M. Kiemeney & Elio Riboli. (2010) Fluid intake and the risk of urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC). International Journal of Cancer 128:11, pages 2695-2708.
Crossref
Crossref
YL Lin, G Sun, XQ Liu, WP Li & JG Ma. (2011)
Clinical Significance of
CDH13
Promoter Methylation in Serum Samples from Patients with Bladder Transitional Cell Carcinoma
. Journal of International Medical Research 39:1, pages 179-186.
Crossref
Crossref
Takuji Tanaka, Katsuhito Miyazawa, Tetsuya Tsukamoto, Toshiya Kuno & Koji Suzuki. (2011) Pathobiology and Chemoprevention of Bladder Cancer. Journal of Oncology 2011, pages 1-23.
Crossref
Crossref
Liang Cheng, Antonio Lopez-Beltran & David G. Bostwick. 2011. Essentials of Anatomic Pathology. Essentials of Anatomic Pathology
1515
1565
.
Antonio Lopez-Beltran, Jose L. Ordóñez, Ana P. Otero, Ana Blanca, Vicky Sevillano, Marta Sanchez-Carbayo, Elisa Muñoz, Liang Cheng, Rodolfo Montironi & Enrique de Alava. (2010) Cyclin D3 gene amplification in bladder carcinoma in situ. Virchows Archiv 457:5, pages 555-561.
Crossref
Crossref
Peter J. Goebell & Margaret A. Knowles. (2010) Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium. Urologic Oncology: Seminars and Original Investigations 28:4, pages 409-428.
Crossref
Crossref
M Unoki, J D Kelly, D E Neal, B A J Ponder, Y Nakamura & R Hamamoto. (2009) UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer. British Journal of Cancer 101:1, pages 98-105.
Crossref
Crossref